Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic ...(ome in Research Triangle Park NC. Bream ...),Health

Steven Butts

Steven Butts has 13 years of experience in the pharmaceutical industry, having held leadership positions in marketing and brand management, sales, new product planning and business development at Eli Lilly and Company, Glaxo Wellcome and Braintree Laboratories. He was the U.S. marketing director of Lilly's ADHD medication Strattera(R), leading the product from phase 2 clinical trials through its second year in market. Butts joined Addrenex from Biobehavioral Diagnostics in Boston, where he served as vice president of marketing and sales. He holds a Master of Business Administration from the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill.

Yuki Prescott

Yuki Prescott came to Addrenex from Constella Group, where she served as project manager and clinical research associate. In her early career, Prescott was a practicing physical therapist in both inpatient and outpatient settings. She has a master's degree in physical therapy from East Carolina University and a bachelor's degree in biology from Binghamton University in Binghamton, NY.